Biotech industry finds a friend in Jay Inslee – Seattle Times
In the run-up to passage of the national health-care law in 2010, Congress was fighting over an obscure provision with billions of dollars at stake: how quickly to allow generic versions of costly new biotech drugs. The biotech industry mounted ...
Subscribe to LegalLaw247.Com Newsletter